Bimeda, Inc. is recalling approximately 10,050 pouches of Griseofulvin Powder (microsize) for oral use in horses. This recall was initiated because laboratory testing found that the medication contained levels of Griseofulvic Acid and a single unknown impurity that exceeded safety and quality specifications. Consumers should contact their veterinarian or pharmacist immediately regarding this medication.
The presence of impurities and higher-than-allowed acid levels above the specified limits (1.2% for Griseofulvic Acid and 0.18% for an unknown impurity) can compromise the drug's safety profile and effectiveness in treating fungal infections in horses.
Veterinary drug return and refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response